SearchThis episode explores the mid-year outlook for the biopharma sector, highlighting cautious optimism driven by strong data, increased M&A activity and emerging biotech resilience.
Biotech Progress Report – a BioCentury podcast
Jul 29, 2025
You may also be interested in